Insider · CIK 0001835647
Catherine Levene
director
Files at PBI (PITNEY BOWES INC /DE/). First filing May 12, 2025, latest May 12, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$1,873 bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PBI: PITNEY BOWES INC /DE/
PBIOct 9, 2026 · close 16.80
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | PBIbuy PITNEY BOWES INC /DE/ | $1,873 200 shares | - | +44% from low-15% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | PBI PITNEY BOWES INC /DE/ | MOption exercise Common Stock | +6,805 | $0.00 | $0 | 7,005 | Nov 24, 2025 |
| Nov 21, 2025 | PBI PITNEY BOWES INC /DE/ | MOption exercise Restricted Stock Unitderivative | -6,805 | $0.00 | $0 | 10,461 | Nov 24, 2025 |
| May 13, 2025 | PBI PITNEY BOWES INC /DE/ | AGrant or award Restricted Stock Unitderivative | +10,461 | $0.00 | $0 | 17,266 | May 14, 2025 |
| May 9, 2025 | PBI PITNEY BOWES INC /DE/ | POpen-market purchase Common Stock | +200 | $9.37 | $1,873 | 200 | May 12, 2025 |
| Nov 21, 2024 | PBI PITNEY BOWES INC /DE/ | AGrant or award Restricted Stock Unitderivative | +6,805 | $0.00 | $0 | 6,805 | Nov 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.